MedPath

Controlled Study of Stage 3 Osteonecrosis Treatment by Bone Marrow

Not Applicable
Completed
Conditions
Non Traumatic Osteonecrosis of the Femoral Head (Hip)
Registration Number
NCT01544712
Lead Sponsor
University of Liege
Brief Summary

In stage 3 Osteonecrosis (ON) of the femoral head, a beneficial effect of bone marrow grafting was reported with a reduction of the functional evolution and the necessity of a total prosthesis placement in a non-controlled retrospective trial. Based on this experience, the investigators would like to start a randomized controlled double blind study on the effect of autologous implantation of autologous bone marrow cells into the necrotic lesion of stage 3 ON of the femoral head.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  1. patients who have a non traumatic ON of the femoral head
  2. Stage 3 ON (subchondral fracture).
  3. Age > 18 years
  4. Be able and willing to participate in the study
Exclusion Criteria
  1. evidence of malignant disorder in the past five years
  2. Patient unable to undergo a MRI.
  3. Patient who is positive for an HIV, hepatitis B or C infection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
reduction of total prosthesis24, 60 months

Need to undergo a surgical treatment total prosthesis

Secondary Outcome Measures
NameTimeMethod
Pain reduction24, 60 months

Visual analogue scale

functional status24, 60 months

Lequesne and WOMAC scores

Trial Locations

Locations (1)

University of Liège

🇧🇪

Liège, Belgium

University of Liège
🇧🇪Liège, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.